Circular Genomics is a startup based in the United States, 1 tracked investor.
Circular Genomics is a startup based in the United States. Brouky records 1 investor associated with the company.
Circular Genomics develops clinical biomarker tests based on circular RNA (circRNA) and associated bioinformatics to diagnose, monitor, and predict treatment response for psychiatric and neurological disorders. The company is building a pipeline of blood-based tests for precision psychiatry and neurology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.